113 related articles for article (PubMed ID: 17089032)
1. Strong expression of chemokine receptor CXCR4 by pancreatic cancer correlates with advanced disease.
Wehler T; Wolfert F; Schimanski CC; Gockel I; Herr W; Biesterfeld S; Seifert JK; Adwan H; Berger MR; Junginger T; Galle PR; Moehler M
Oncol Rep; 2006 Dec; 16(6):1159-64. PubMed ID: 17089032
[TBL] [Abstract][Full Text] [Related]
2. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
3. Chemokine receptor CXCR4 expression, function, and clinical implications in gastric cancer.
Lee HJ; Kim SW; Kim HY; Li S; Yun HJ; Song KS; Kim S; Jo DY
Int J Oncol; 2009 Feb; 34(2):473-80. PubMed ID: 19148483
[TBL] [Abstract][Full Text] [Related]
4. Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer.
Schimanski CC; Schwald S; Simiantonaki N; Jayasinghe C; Gönner U; Wilsberg V; Junginger T; Berger MR; Galle PR; Moehler M
Clin Cancer Res; 2005 Mar; 11(5):1743-50. PubMed ID: 15755995
[TBL] [Abstract][Full Text] [Related]
5. Expression of CXCR4 and its ligand SDF-1 in intestinal-type gastric cancer is associated with lymph node and liver metastasis.
Iwasa S; Yanagawa T; Fan J; Katoh R
Anticancer Res; 2009 Nov; 29(11):4751-8. PubMed ID: 20032431
[TBL] [Abstract][Full Text] [Related]
6. The chemokine receptor CXCR4 is more frequently expressed in breast compared to other metastatic adenocarcinomas in effusions.
Davidson B; Dong HP; Holth A; Berner A; Risberg B
Breast J; 2008; 14(5):476-82. PubMed ID: 18657145
[TBL] [Abstract][Full Text] [Related]
7. CXCR4 membrane expression in node-negative breast cancer.
Blot E; Laberge-Le Couteulx S; Jamali H; Cornic M; Guillemet C; Duval C; Hellot MF; Pille JY; Picquenot JM; Veyret C
Breast J; 2008; 14(3):268-74. PubMed ID: 18373506
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor-gamma and retinoid X receptor-alpha expression in pancreatic ductal adenocarcinoma: association with clinicopathological parameters, tumor proliferative capacity, and patients' survival.
Giaginis C; Katsamangou E; Tsourouflis G; Zizi-Serbetzoglou D; Kouraklis G; Theocharis S
Med Sci Monit; 2009 May; 15(5):BR148-56. PubMed ID: 19396032
[TBL] [Abstract][Full Text] [Related]
9. The CXCR4-CXCL12 pathway facilitates the progression of pancreatic cancer via induction of angiogenesis and lymphangiogenesis.
Cui K; Zhao W; Wang C; Wang A; Zhang B; Zhou W; Yu J; Sun Z; Li S
J Surg Res; 2011 Nov; 171(1):143-50. PubMed ID: 20462600
[TBL] [Abstract][Full Text] [Related]
10. Beta-catenin is a promising key factor in the SDF-1/CXCR4 axis on metastasis of pancreatic cancer.
Wang Z; Ma Q
Med Hypotheses; 2007; 69(4):816-20. PubMed ID: 17379424
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
Na IK; Scheibenbogen C; Adam C; Stroux A; Ghadjar P; Thiel E; Keilholz U; Coupland SE
Hum Pathol; 2008 Dec; 39(12):1751-5. PubMed ID: 18701133
[TBL] [Abstract][Full Text] [Related]
12. CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC; Paul S; Altorki NK; Saqi A
J Thorac Cardiovasc Surg; 2009 Mar; 137(3):615-21. PubMed ID: 19258077
[TBL] [Abstract][Full Text] [Related]
13. Altered chemokine receptor expression in papillary thyroid cancer.
González HE; Leiva A; Tobar H; Böhmwald K; Tapia G; Torres J; Mosso LM; Bueno SM; Gonzalez P; Kalergis AM; Riedel CA
Thyroid; 2009 Sep; 19(9):957-65. PubMed ID: 19731977
[TBL] [Abstract][Full Text] [Related]
14. Zerumbone down-regulates chemokine receptor CXCR4 expression leading to inhibition of CXCL12-induced invasion of breast and pancreatic tumor cells.
Sung B; Jhurani S; Ahn KS; Mastuo Y; Yi T; Guha S; Liu M; Aggarwal BB
Cancer Res; 2008 Nov; 68(21):8938-44. PubMed ID: 18974138
[TBL] [Abstract][Full Text] [Related]
15. Low-level expression of Smad7 correlates with lymph node metastasis and poor prognosis in patients with pancreatic cancer.
Wang P; Fan J; Chen Z; Meng ZQ; Luo JM; Lin JH; Zhou ZH; Chen H; Wang K; Xu ZD; Liu LM
Ann Surg Oncol; 2009 Apr; 16(4):826-35. PubMed ID: 19165547
[TBL] [Abstract][Full Text] [Related]
16. Relations among expression of CXCR4, histological patterns, and metastatic potential in adenoid cystic carcinoma of the head and neck.
Zushi Y; Noguchi K; Hashitani S; Sakurai K; Segawa E; Takaoka K; Toyohara Y; Tanaka N; Kishimoto H; Urade M
Int J Oncol; 2008 Dec; 33(6):1133-9. PubMed ID: 19020745
[TBL] [Abstract][Full Text] [Related]
17. Recombination of CXCR4, VEGF, and MMP-9 predicting lymph node metastasis in human breast cancer.
Hao L; Zhang C; Qiu Y; Wang L; Luo Y; Jin M; Zhang Y; Guo TB; Matsushima K; Zhang Y
Cancer Lett; 2007 Aug; 253(1):34-42. PubMed ID: 17306924
[TBL] [Abstract][Full Text] [Related]
18. Elevated levels of chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
Holm NT; Byrnes K; Li BD; Turnage RH; Abreo F; Mathis JM; Chu QD
J Surg Res; 2007 Jul; 141(1):53-9. PubMed ID: 17574038
[TBL] [Abstract][Full Text] [Related]
19. [Quantitative analysis and significance of CXCL12 and CXCR4 expression with lymphangiogenesis of pancreatic adenocarcinoma].
Fei LM; Wang CL; Zhao WH; Cui K; Zhang B; Zhou WY; Zhong WX; Li S
Zhonghua Wai Ke Za Zhi; 2009 May; 47(10):783-6. PubMed ID: 19615218
[TBL] [Abstract][Full Text] [Related]
20. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]